Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+cell count to guide pre-emptive or immediate rescue mobilization.-Reference-Cited by-同舟云学术

Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+cell count to guide pre-emptive or immediate rescue mobilization.

Published:2012-08 Issue:7 Volume:14 Page:823-829
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Sancho Juan-Manuel,Morgades Mireia,Grifols Joan-Ramon,Juncà Jordi,Guardia Ramon,Vives Susana,Ferrà Christelle,Batlle Monsterrat,Ester Anna,Gallardo David,Millà Fuensanta,Feliu Evarist,Ribera Josep-Maria

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference40 articles.

1. The biology and clinical uses of blood stem cells;To;Blood,1997

2. What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?;Jillella;Stem Cells Dev,2004

3. Advances in mobilization for the optimization of autologous stem cell transplantation;Vose;Leuk Lymphoma,2009

4. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy;Sheridan;Lancet,1992

5. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants;To;Bone Marrow Transplant,1992

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline inflammation indexes and neutrophil‐to‐LDH ratio for prediction of the first mobilization failure without plerixafor‐based regimens in multiple myeloma and lymphoma patients: A single‐center retrospective study;Journal of Clinical Apheresis;2023-08-14

2. The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma;Marmara Medical Journal;2023-01-31

3. Plerixafor and granulocyte colony stimulating factor for poor mobilizers in patients undergoing autologous peripheral hematopoietic stem cell transplantation: Single institution study;Frontiers in Transplantation;2023-01-18

4. EVALUATION OF AN ALGORITHM FOR STEM CELL MOBILIZATION WITH COMBINED ON-DEMAND PLERIXAFOR USE IN AUTOLOGOUS PERIPHERAL BLOOD STEM CELL COLLECTION;Japanese Journal of Transfusion and Cell Therapy;2022-12-20

5. Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients;Transfusion Medicine and Hemotherapy;2022-09-05